Colodiag®
An accurate blood-based test
for the screening of colorectal cancer (CRC)
Workflow

Clinical validation in 2021
Training set: preliminary results


Peltier J, Roperch JP, Audebert S, Borg JP and Camoin L. Activation peptide of the coagulation factor XIII (AP-F13A1) as a new biomarker for the screening of colorectal cancer. Clinical Proteomics. 2018 15:15
https://doi.org/10.1186/s12014-018-9191-3
Peltier J, Roperch JP, Audebert S, Borg JP and Camoin L. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family. J Proteomics. 2016 Aug; 148:139-48
https://doi.org/10.1016/j.jprot.2016.07.031